Overview

Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
To determine whether peripheral low dose systemic thrombolysis (PLST) is non-inferior to catheter directed acoustic pulse thrombolysis (ACDT) in improving RV function and reducing pulmonary artery pressures in submassive pulmonary embolism (PE)
Phase:
Phase 4
Details
Lead Sponsor:
Northwell Health
Treatments:
Tissue Plasminogen Activator